Myosin1f-mediated neutrophil migration contributes to acute neuroinflammation and brain injury after stroke in mice

Abstract

Background During the acute stroke phase, neutrophils from the peripheral blood are first to arrive in the ischemic brain, which then attracts other immune cells that exacerbate neuroinflammation in the ischemic tissue. Myosin1f was reported to specifically mediate neutrophil migration in the peripheral tissues, but whether it plays a critical role in the neuroinflammatory response after ischemic stroke remains unknown. In this study, we aim to test the hypothesis that myosin1f-mediated neutrophil migration is critical in acute neuroinflammation induced by ischemic stroke. Methods Myosin1f −/− and wild type (WT) mice were subjected to transient middle cerebral artery occlusion (MCAO). To determine which cells determine myosin1f’s transmigration ability, bone marrow transplantation, neutrophil depletion, and adoptive neutrophil transfer were performed. The myosin1f RNA level was assessed in peripheral neutrophils by reverse transcription polymerase chain reaction (RT-PCR) at 1 day and 3 days after stroke. The infiltrating neutrophils were quantified by immunofluorescence staining and FACS at 72 h after reperfusion. Results The myosin1f −/− mice had significantly smaller infarctions than the myosin1f +/+ mice. Bone marrow transplantation from myosin1f −/− mice to recipient mice also had smaller infarctions compared to animals receiving bone marrow from myosin1f +/+ mice. By performing neutrophil depletion and adoptive transfer, we confirmed that myosin1f acts mainly in circulating neutrophils. RT-PCR showed that myosin1f gene expression was increased in the circulating blood neutrophils at 3 days after ischemia. The confocal immunostaining and FACS results confirmed that fewer neutrophils infiltrated into the ischemic brain in myosin1f −/− mice compared to WT mice. Conclusions Myosin1f determines neutrophil migration into the ischemic hemisphere, which directly affects stroke outcome. Electronic supplementary material The online version of this article (10.1186/s12974-019-1465-9) contains supplementary material, which is available to authorized users.

RETRACTED ARTICLE: Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction

“…According to the data released by the World Health Organization, stroke has become the second leading cause of death worldwide in the past 10 years from 2000 to 2012 [ 2 ]. Among them, ischemic cerebral infarction is the most common type of stroke, which occurs after cervical or cerebral blood flow is blocked [ 3 ]. Due to the active metabolism of the brain, more oxygen is needed.…”

Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia

“…Growing evidence suggests that neuroinflammation and the immune system contribute importantly to the development and maintenance of neuropathic pain [8,9]. Neuroinflammation results from the activation of glial cells, including satellite glial cells, microglia, and astrocytes, in the peripheral and central nervous system as well as the activation of immune cells including resident mast cells, infiltrating macrophages, and neutrophils [10][11][12][13]. Microglia, the main immunocompetent cells in the central nervous system (CNS) that regulate homeostasis in the brain and spinal cord, represent 5-10% of the glia in the CNS.…”

Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra

“…Such interrelationship supports the microglia source of those cytokines, although they could also come from the infiltrating immune cells that showed a similar time course. Together, these findings show that the BSSGinduced neuroinflammation is chronic, similar to the one occurring in Parkinson's disease but in contrast to the acute response induced by LPS [44], traumatic brain injury [66], or transient ischemia [67]. In the acute neuroinflammation by LPS, TNF-α and IL-1β reached maximum levels at 5 h after the lesion and at 8 h for IL-6 [44].…”